Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 29

    1.

    Adenocarcinoma in a 40-year-old colonic interposition treated with Ivor Lewis esophagectomy and esophagogastric anastomosis.

    Shersher DD, Hong E, Warren W, Penfield Faber L, Liptay MJ.

    Ann Thorac Surg. 2011 Dec;92(6):e113-4.

    PMID:
    22115265
    [PubMed - indexed for MEDLINE]
    2.

    Is prophylactic thoracic duct ligation warranted in all patients undergoing esophagectomy?

    Jiwnani S, Karimundackal G, Mehta M, Pramesh CS.

    Ann Thorac Surg. 2011 Dec;92(6):2302; author reply 2302. No abstract available.

    PMID:
    22115256
    [PubMed - indexed for MEDLINE]
    3.

    Hiatal hernia after esophagectomy: analysis of 2,182 esophagectomies from a single institution.

    Price TN, Allen MS, Nichols FC 3rd, Cassivi SD, Wigle DA, Shen KR, Deschamps C.

    Ann Thorac Surg. 2011 Dec;92(6):2041-5.

    PMID:
    22115216
    [PubMed - indexed for MEDLINE]
    4.

    Invited commentary.

    Iannettoni MD.

    Ann Thorac Surg. 2011 Dec;92(6):2040. No abstract available.

    PMID:
    22115215
    [PubMed - indexed for MEDLINE]
    5.

    Invited commentary.

    Hagen JA.

    Ann Thorac Surg. 2011 Dec;92(6):2027. No abstract available.

    PMID:
    22115213
    [PubMed - indexed for MEDLINE]
    6.

    Morbidity and mortality after esophagectomy following neoadjuvant chemoradiation.

    Merritt RE, Whyte RI, D'Arcy NT, Hoang CD, Shrager JB.

    Ann Thorac Surg. 2011 Dec;92(6):2034-40. Epub 2011 Sep 25.

    PMID:
    21945223
    [PubMed - indexed for MEDLINE]
    7.

    The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.

    Paulson L, Shindo M, Schuff K, Corless C.

    Arch Otolaryngol Head Neck Surg. 2012 Jan;138(1):44-9.

    PMID:
    22249628
    [PubMed - indexed for MEDLINE]
    8.

    Efficacy and safety of central compartment neck dissection for recurrent thyroid carcinoma.

    Shah MD, Harris LD, Nassif RG, Kim D, Eski S, Freeman JL.

    Arch Otolaryngol Head Neck Surg. 2012 Jan;138(1):33-7.

    PMID:
    22249626
    [PubMed - indexed for MEDLINE]
    9.

    Long-term health-related quality of life in survivors of head and neck cancer.

    Funk GF, Karnell LH, Christensen AJ.

    Arch Otolaryngol Head Neck Surg. 2012 Feb;138(2):123-33. Epub 2012 Jan 16.

    PMID:
    22248560
    [PubMed - indexed for MEDLINE]
    10.

    A population-based study of therapy and survival for patients with head and neck cancer treated in the community.

    Dansky Ullmann C, Harlan LC, Shavers VL, Stevens JL.

    Cancer. 2012 Jan 17. doi: 10.1002/cncr.27419. [Epub ahead of print]

    PMID:
    22252676
    [PubMed - as supplied by publisher]
    11.

    Prospective trial of synchronous bevacizumab, erlotinib, and concurrent chemoradiation in locally advanced head and neck cancer.

    Yoo DS, Kirkpatrick JP, Craciunescu O, Broadwater G, Peterson BL, Carroll MD, Clough R, MacFall JR, Hoang J, Scher RL, Esclamado RM, Dunphy FR, Ready NE, Brizel DM.

    Clin Cancer Res. 2012 Mar 1;18(5):1404-14. Epub 2012 Jan 17.

    PMID:
    22253412
    [PubMed - in process]
    12.

    Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival.

    Gubanova E, Brown B, Ivanov SV, Helleday T, Mills GB, Yarbrough WG, Issaeva N.

    Clin Cancer Res. 2012 Mar 1;18(5):1257-67. Epub 2012 Jan 13.

    PMID:
    22247495
    [PubMed - in process]
    13.

    Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements.

    Hayes DN, Lucas AS, Tanvetyanon T, Krzyzanowska MK, Chung CH, Murphy BA, Gilbert J, Mehra R, Moore DT, Sheikh A, Hoskins J, Hayward MC, Zhao N, O'Connor W, Weck KE, Cohen RB, Cohen EE.

    Clin Cancer Res. 2012 Apr 1;18(7):2056-65. Epub 2012 Jan 12.

    PMID:
    22241789
    [PubMed - in process]
    14.

    Preoperative prediction of papillary thyroid carcinoma prognosis with the assistance of computerized morphometry of cytology samples obtained by fine-needle aspiration: Preliminary report.

    Shih SR, Chang YC, Li HY, Liau JY, Lee CY, Chen CM, Chang TC.

    Head Neck. 2012 Jan 13. doi: 10.1002/hed.22909. [Epub ahead of print]

    PMID:
    22247012
    [PubMed - as supplied by publisher]
    15.

    Phase I Trial Using the Proteasome Inhibitor Bortezomib and Concurrent Chemoradiotherapy for Head-and-Neck Malignancies.

    Kubicek GJ, Axelrod RS, Machtay M, Ahn PH, Anne PR, Fogh S, Cognetti D, Myers TJ, Curran WJ Jr, Dicker AP.

    Int J Radiat Oncol Biol Phys. 2012 Jan 13. [Epub ahead of print]

    PMID:
    22245208
    [PubMed - as supplied by publisher]
    16.

    A new brain positron emission tomography scanner with semiconductor detectors for target volume delineation and radiotherapy treatment planning in patients with nasopharyngeal carcinoma.

    Katoh N, Yasuda K, Shiga T, Hasegawa M, Onimaru R, Shimizu S, Bengua G, Ishikawa M, Tamaki N, Shirato H.

    Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e671-6. Epub 2012 Jan 13.

    PMID:
    22245187
    [PubMed - indexed for MEDLINE]
    17.

    Response to "The correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy (IMRT) for head-and-neck cancer." (Int J Radiat Oncol Biol Phys 2011;81:e207-e213.).

    Thariat J, Marcy PY, Darcourt V, Vincent S, Lacout A.

    Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):520; author reply 520. No abstract available.

    PMID:
    22244279
    [PubMed - indexed for MEDLINE]
    18.

    Postradiotherapy neck dissection: an obsolete treatment paradigm?

    Quon H, Lavertu P.

    Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):502-4. No abstract available.

    PMID:
    22244275
    [PubMed - indexed for MEDLINE]
    19.

    Eight-signature classifier for prediction of nasopharyngeal [corrected] carcinoma survival.

    Wang HY, Sun BY, Zhu ZH, Chang ET, To KF, Hwang JS, Jiang H, Kam MK, Chen G, Cheah SL, Lee M, Liu ZW, Chen J, Zhang JX, Zhang HZ, He JH, Chen FL, Zhu XD, Huang MY, Liao DZ, Fu J, Shao Q, Cai MB, Du ZM, Yan LX, Hu CF, Ng HK, Wee JT, Qian CN, Liu Q, Ernberg I, Ye W, Adami HO, Chan AT, Zeng YX, Shao JY.

    J Clin Oncol. 2011 Dec 1;29(34):4516-25. Epub 2011 Oct 24. Erratum in: J Clin Oncol. 2012 Feb 20;30(6):679.

    PMID:
    22025164
    [PubMed - indexed for MEDLINE]
    20.

    S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma.

    Leichman LP, Goldman BH, Bohanes PO, Lenz HJ, Thomas CR, Billingsley KG, Corless CL, Iqbal S, Gold PJ, Benedetti JK, Danenberg KD, Blanke CD.

    J Clin Oncol. 2011 Dec 1;29(34):4555-60. Epub 2011 Oct 24.

    PMID:
    22025151
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk